3,4-Dimethylpentanol-2 | 64502-86-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3,4-Dimethylpentanol-2
• 英文别名: 3,4-dimethyl-pentan-2-ol；3,4-Dimethylpentan-2-ol
• CAS: 64502-86-9
• 化学式: C₇H₁₆O
• 分子量: 116.203
• InChiKey: SODKTKJZYBOMMT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  8
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3,4-Dimethylpentanol-2 在 氢碘酸 作用下， 生成 2-iodo-3,4-dimethyl-pentane
  参考文献：
  名称：

  Willstaetter; Hatt, Justus Liebigs Annalen der Chemie, 1919, vol. 418, p. 152

  摘要：

  DOI：
• 作为产物：
  描述：

  3,4-dimethyl-2-pentanone 在 乙醇 、 sodium 作用下， 生成 3,4-Dimethylpentanol-2
  参考文献：
  名称：

  Willstaetter; Hatt, Justus Liebigs Annalen der Chemie, 1919, vol. 418, p. 152

  摘要：

  DOI：

文献信息

• OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME
  申请人：SHIOZAKI Hiroyoshi

  公开号：US20090306376A1

  公开（公告）日：2009-12-10

  A compound comprising a ring structure including a ring composed of four carbon atoms and two nitrogen atoms and a substituted or unsubstituted amino group bonded to the ring structure.

  一种化合物，包括一个环结构，其中包括由四个碳原子和两个氮原子组成的环，以及与环结构相结合的取代或未取代的氨基团。
• Morpholine type cinnamide compound
  申请人：Kimura Teiji

  公开号：US20070117798A1

  公开（公告）日：2007-05-24

  The present invention relates to a compound represented by the formula (I): or a pharmacologically acceptable salt thereof, wherein R 1 , R 2 , R 3 , and R 4 are the same or different and each represent a hydrogen atom or a C1-6 alkyl group; X 1 represents a C1-6 alkylene group that may be substituted; X a represents a methoxy group or a fluorine atom; X b represents an oxygen atom or a methylene group, provided that X b is only an oxygen atom when X a is a methoxy group; and Ar 1 represents an aryl group, pyridinyl group, aryloxy group, or pyridinyloxy group that may have a substituent such as a halogen atom; and to use of the compound or salt as a pharmaceutical agent.

  本发明涉及一种由式(I)表示的化合物或其药理学上可接受的盐，其中R1、R2、R3和R4相同或不同，并且每个代表氢原子或C1-6烷基基团；X1代表可能被取代的C1-6烷基基团；Xa代表甲氧基团或氟原子；Xb代表氧原子或亚甲基基团，前提是当Xa为甲氧基团时，Xb仅为氧原子；Ar1代表可能具有卤素原子等取代基的芳基、吡啶基、芳氧基或吡啶氧基；以及将该化合物或盐用作药物剂的用途。
• COOLING SENSATION AGENT COMPOSITION, SENSORY STIMULATION AGENT COMPOSITION AND USE OF THE SAME
  申请人：Komatsuki Yasuhiro

  公开号：US20110081393A1

  公开（公告）日：2011-04-07

  Disclosed is a cooling sensation agent composition or sensory stimulation agent composition which contains at least one of diester compounds of dicarboxylic acid represented by the formula (1) wherein A represents CH 2 or CH═CH, n represents an integer of 0 to 4 when A is CH 2 , or 1 when A is CH═CH, B is an alcohol residue having 10 to 18 carbon atoms and containing a para-menthane skeleton, which may have a substituent, and C is an alcohol residue having 6 to 18 carbon atoms, which may have a substituent as well as a flavor or fragrance composition, a beverage, a food product, a perfume or cosmetic product, a toiletry product, daily utensil products or groceries, a fiber, a fiber product, clothes, clothing or a medicine, wherein the cooling sensation agent composition or the sensory stimulation agent composition is compounded.

  本文披露了一种包含以下化学式（1）所代表的二羧酸双酯化合物之一的冷却感剂组合物或感官刺激剂组合物，其中A代表CH2或CH═CH，n代表整数0至4（当A为CH2时）或1（当A为CH═CH时），B是含有10至18个碳原子并含有对蒎烷骨架的醇残基，可能有取代基，C是含有6至18个碳原子的醇残基，可能也有取代基，以及香料或香精组合物、饮料、食品产品、香水或化妆品产品、洗涤用品、日用品或杂货、纤维、纤维制品、衣服、服装或药品，其中复合了冷却感剂组合物或感官刺激剂组合物。
• Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
  申请人：Goble D. Stephen

  公开号：US20070117797A1

  公开（公告）日：2007-05-24

  Compounds of the formula (I) which are modulators of chemokine receptor activity useful in the prevention or treatment of certain inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis, and pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which chemokine receptors are involved.

  公式(I)的化合物是化学趋化因子受体活性调节剂，对预防或治疗某些炎症和免疫调节性疾病和疾病、过敏性疾病、包括过敏性鼻炎、皮炎、结膜炎和哮喘等特应性疾病，以及风湿性关节炎和动脉粥样硬化等自身免疫病理学，以及包含这些化合物的药物组合物，以及这些化合物和组合物在涉及化学趋化因子受体的疾病的预防或治疗中的用途。
• Palladium-Catalyzed Isomerization of<i>exo</i>-Methylenic Allylic Alcohols
  作者：Paul S. Fordred、D. Gangani Niyadurupola、Richard Wisedale、Steven D. Bull

  DOI：10.1002/adsc.200900309

  日期：2009.10

  Treatment of allylic alcohols containing a 1,1-disubstituted alkene with a palladium catalyst and hydrogen gas (1 bar) results in facile isomerization to their corresponding trisubstituted (E)-allylic alcohols, along with small amounts of the corresponding hydrogenated products.

  用钯催化剂和氢气（1bar）处理含有1，1-二取代的烯烃的烯丙基醇，以及少量的相应的氢化产物，容易地异构化为它们相应的三取代的（E）-烯丙基醇。